Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$144.95 - $152.29 $4.04 Million - $4.25 Million
27,888 Added 23.9%
144,596 $21.9 Million
Q2 2022

Aug 10, 2022

SELL
$83.14 - $145.99 $62,355 - $109,492
-750 Reduced 0.64%
116,708 $17 Million
Q1 2022

May 04, 2022

BUY
$110.08 - $142.92 $888,235 - $1.15 Million
8,069 Added 7.38%
117,458 $13.9 Million
Q4 2021

Feb 10, 2022

SELL
$99.73 - $148.48 $175,425 - $261,176
-1,759 Reduced 1.58%
109,389 $15.1 Million
Q3 2021

Nov 10, 2021

BUY
$98.85 - $138.91 $303,172 - $426,036
3,067 Added 2.84%
111,148 $15.4 Million
Q2 2021

Aug 13, 2021

BUY
$65.78 - $105.02 $180,697 - $288,489
2,747 Added 2.61%
108,081 $10.5 Million
Q1 2021

May 14, 2021

SELL
$64.07 - $91.75 $343,927 - $492,514
-5,368 Reduced 4.85%
105,334 $7.2 Million
Q4 2020

Feb 02, 2021

BUY
$65.07 - $98.24 $117,776 - $177,814
1,810 Added 1.66%
110,702 $9.49 Million
Q3 2020

Nov 05, 2020

BUY
$59.04 - $77.95 $768,936 - $1.02 Million
13,024 Added 13.59%
108,892 $7.08 Million
Q2 2020

Aug 12, 2020

BUY
$29.01 - $74.23 $207,131 - $530,002
7,140 Added 8.05%
95,868 $7.01 Million
Q1 2020

May 12, 2020

SELL
$27.51 - $57.29 $1.41 Million - $2.94 Million
-51,265 Reduced 36.62%
88,728 $3.02 Million
Q4 2019

Jan 27, 2020

BUY
$40.86 - $57.65 $3.12 Million - $4.4 Million
76,265 Added 119.67%
139,993 $7.62 Million
Q3 2019

Oct 31, 2019

BUY
$37.38 - $49.47 $1.29 Million - $1.71 Million
34,597 Added 118.76%
63,728 $2.66 Million
Q2 2019

Aug 15, 2019

BUY
$39.79 - $67.01 $266,831 - $449,369
6,706 Added 29.9%
29,131 $1.28 Million
Q1 2019

May 03, 2019

BUY
$34.52 - $53.29 $166,559 - $257,124
4,825 Added 27.41%
22,425 $1.15 Million
Q4 2018

Feb 08, 2019

SELL
$29.75 - $42.9 $26,775 - $38,610
-900 Reduced 4.86%
17,600 $651,000
Q3 2018

Nov 13, 2018

SELL
$32.79 - $43.0 $49,185 - $64,500
-1,500 Reduced 7.5%
18,500 $695,000
Q2 2018

Aug 15, 2018

BUY
$23.62 - $42.29 $472,400 - $845,800
20,000 New
20,000 $790,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.